IBD: Mucosal healing - EXTENDing our knowledge in Crohn's disease

Silvio Danese, Laurent Peyrin-Biroulet

Research output: Contribution to journalArticlepeer-review


Evidence has accumulated to show that mucosal healing can alter the course of Crohn's disease. New results from the EXTEND trial clearly demonstrate that adalimumab is able to induce and maintain mucosal healing in Crohn's disease and has the potential for disease modification.

Original languageEnglish
Pages (from-to)309-311
Number of pages3
JournalNature Reviews Gastroenterology and Hepatology
Issue number6
Publication statusPublished - Jun 2012

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology


Dive into the research topics of 'IBD: Mucosal healing - EXTENDing our knowledge in Crohn's disease'. Together they form a unique fingerprint.

Cite this